The over-the-counter (OTC), drug-free medical device, ActiPatch®, has obtained a new 510(k) clearance from the Food and Drug Administration (FDA) for the adjunctive treatment of musculoskeletal pain.
Investigators assessed sex differences in interleukin-6 response after exposure to acute pain among patients with knee osteoarthritis who were scheduled for total knee arthroplasty.
Researchers assessed and compared the effectiveness of neurodynamic mobilization techniques with passive robotic physiologic movement for patients with hand osteoarthritis.
Data from a study investigating the efficacy and safety of 6-week low-dose prednisolone in patients with painful hand osteoarthritis were presented at the 2019 ACR Annual Meeting.
Patients on long-term opioid treatment for chronic pain reported experiencing negative physical side effects, emotional distress, and degraded relationships with their primary care provider.
Opioids offer minor pain relief and functional benefits in patients with osteoarthritis (OA), with smaller benefits regarding pain for strong versus weak opioids.
This study evaluated previously unreported data from the NHANES 2009-2010 and NHANES 2 (1976-1980) questionnaires that were used to compare axial pain rates among patients with and without inflammatory bowel disease.
Higher levels of total testosterone were found to be associated with reduced pain intensity in the operated knee of patients who underwent total knee replacement for severe knee osteoarthritis.
Doctors should be more cautious when taking chronic pain patients off opioid painkillers.
The levels of urine C-telopeptide of cross-linked collagen type II were found to be independently associated with pain intensity and radiographic severity in patients with osteoarthritis.
